Amgen (AMGN) Price Target Trimmed at Morgan Stanley as Policy Risks Ease [Yahoo! Finance]
Morgan Stanley (MS)
Last morgan stanley earnings: 4/16 07:15 am
Check Earnings Report
US:NYSE Investor Relations:
morganstanley.com/about-us-ir
Company Research
Source: Yahoo! Finance
On December 12, Morgan Stanley cut its price target for Amgen Inc. (NASDAQ:AMGN) from $329 to $304, but kept its Equal Weight rating. The firm's 2026 biopharma outlook sounds more optimistic, noting that a lot of the policy headaches that dragged the industry down this year will finally ease up. With that out of the way, investors can start paying attention to how these companies are actually performing. Just a few days earlier, on December 9, Amgen Inc. (NASDAQ:AMGN) announced that it's boosting its quarterly dividend by 6%, raising it to $2.52 per share. That marks 15 years in a row of dividend increases, making it one of the most reliable income stocks. Amgen Inc. (NASDAQ:AMGN)'s third quarter of 2025 looked strong. Revenue jumped 12% compared to last year, and volumes climbed 14%. Sixteen of its products posted double-digit growth. The company also rolled out AmgenNow, a direct-to-patient platform in the US for Repatha, its injectable that helps lower LDL cholesterol. Manag
Show less
Read more
Impact Snapshot
Event Time:
MS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MS alerts
High impacting Morgan Stanley news events
Weekly update
A roundup of the hottest topics
MS
News
- How Recent Catalysts Are Shifting the Chevron Narrative for Free Cash Flow and Growth [Yahoo! Finance]Yahoo! Finance
- Merck (MRK) Price Target Lifted at Morgan Stanley as Biopharma Outlook Improves [Yahoo! Finance]Yahoo! Finance
- Bank of America (BAC) Target Cut at Morgan Stanley on Earnings Revisions [Yahoo! Finance]Yahoo! Finance
- Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript [Seeking Alpha]Seeking Alpha
- Shoals (SHLS) Stock Trades Down, Here Is Why [Yahoo! Finance]Yahoo! Finance
MS
Earnings
- 10/16/25 - Beat
MS
Sec Filings
- 12/16/25 - Form 424B2
- 12/16/25 - Form 424B2
- 12/16/25 - Form 424B2
- MS's page on the SEC website